NM_000535.7(PMS2):c.65C>A (p.Ser22Ter) AND Hereditary nonpolyposis colorectal neoplasms

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Jun 26, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001383035.6

Allele description [Variation Report for NM_000535.7(PMS2):c.65C>A (p.Ser22Ter)]

NM_000535.7(PMS2):c.65C>A (p.Ser22Ter)

Gene:

PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7p22.1

Genomic location:

Preferred name:

NM_000535.7(PMS2):c.65C>A (p.Ser22Ter)

HGVS:

NC_000007.14:g.6005990G>T
NG_008466.1:g.8117C>A
NG_050738.1:g.1740G>T
NM_000535.7:c.65C>AMANE SELECT
NM_001322003.2:c.-341C>A
NM_001322004.2:c.-242-1932C>A
NM_001322005.2:c.-341C>A
NM_001322006.2:c.65C>A
NM_001322007.2:c.-151C>A
NM_001322008.2:c.-52-1932C>A
NM_001322009.2:c.-341C>A
NM_001322010.2:c.-242-1932C>A
NM_001322011.2:c.-820C>A
NM_001322012.2:c.-820C>A
NM_001322013.2:c.-341C>A
NM_001322014.2:c.65C>A
NM_001322015.2:c.-420C>A
NP_000526.2:p.Ser22Ter
NP_001308935.1:p.Ser22Ter
NP_001308943.1:p.Ser22Ter
LRG_161t1:c.65C>A
LRG_161:g.8117C>A
NC_000007.13:g.6045621G>T
NM_000535.5:c.65C>A
NR_136154.1:n.152C>A

Protein change:

S22*

Links:

dbSNP: rs767028531

NCBI 1000 Genomes Browser:

rs767028531

Molecular consequence:

NM_001322003.2:c.-341C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322005.2:c.-341C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322007.2:c.-151C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322009.2:c.-341C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322011.2:c.-820C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322012.2:c.-820C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322013.2:c.-341C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322015.2:c.-420C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322004.2:c.-242-1932C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001322008.2:c.-52-1932C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001322010.2:c.-242-1932C>A - intron variant - [Sequence Ontology: SO:0001627]
NR_136154.1:n.152C>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NM_000535.7:c.65C>A - nonsense - [Sequence Ontology: SO:0001587]
NM_001322006.2:c.65C>A - nonsense - [Sequence Ontology: SO:0001587]
NM_001322014.2:c.65C>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:: Hereditary nonpolyposis colorectal neoplasms
Identifiers:: MeSH: D003123; MedGen: C0009405

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001582044	Invitae	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Pathogenic (Jun 26, 2023)	germline	clinical testing	PubMed (4) [See all records that cite these PMIDs] 26320870, 21376568, 24362816, 28492532

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001582044

Invitae

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Pathogenic
(Jun 26, 2023)

germline

clinical testing

PubMed (4)
[See all records that cite these PMIDs]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2.

Li J, Dai H, Feng Y, Tang J, Chen S, Tian X, Gorman E, Schmitt ES, Hansen TA, Wang J, Plon SE, Zhang VW, Wong LJ.

J Mol Diagn. 2015 Sep;17(5):545-53. doi: 10.1016/j.jmoldx.2015.04.001.

PubMed [citation]

PMID:: 26320870

Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: case series, review and follow-up guidelines.

Herkert JC, Niessen RC, Olderode-Berends MJ, Veenstra-Knol HE, Vos YJ, van der Klift HM, Scheenstra R, Tops CM, Karrenbeld A, Peters FT, Hofstra RM, Kleibeuker JH, Sijmons RH.

Eur J Cancer. 2011 May;47(7):965-82. doi: 10.1016/j.ejca.2011.01.013. Epub 2011 Mar 4. Review.

PubMed [citation]

PMID:: 21376568

See all PubMed Citations (4)

Details of each submission

From Invitae, SCV001582044.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (4)

Description

This premature translational stop signal has been observed in individual(s) with clinical features of PMS2-related conditions (PMID: 26320870). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 826502). This variant is present in population databases (rs767028531, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Ser22*) in the PMS2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PMS2 are known to be pathogenic (PMID: 21376568, 24362816).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 7, 2024

ClinVar

Relating variation to medicine